Overview
Michael Xiong is a Dermatologist in Longview, Washington. Dr. Xiong and is rated as an Experienced provider by MediFind in the treatment of Xeroderma Pigmentosum. His top areas of expertise are Basal Cell Skin Cancer, Trichothiodystrophy, Head and Neck Squamous Cell Carcinoma (HNSCC), and Squamous Cell Skin Carcinoma. Dr. Xiong is currently accepting new patients.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Xeroderma Pigmentosum.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- BridgeSpan
- Premera
- Regence
- Prominence Health
- Humana
Locations
1338 Commerce Ave, Suite 106, Longview, WA 98632
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Jon Hanifin is a Dermatologist in Portland, Oregon. Dr. Hanifin and is rated as a Distinguished provider by MediFind in the treatment of Xeroderma Pigmentosum. His top areas of expertise are Atopic Dermatitis, Psoriasis, Xeroderma Pigmentosum, and Plaque Psoriasis.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Experienced
- Basal Cell Skin Cancer
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Kienbock's Disease
- Neurofibromatosis
- Neurofibromatosis Type 1 (NF1)
- Squamous Cell Skin Carcinoma